|
Issue |
Title |
|
Vol 20, No 2 (2025) |
Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms |
Abstract
PDF (Rus)
|
O. Yu. Vinogradova, A. L. Neverova, M. V. Chernikov, V. P. Kosenkova, M. M. Pankrashkina, D. I. Shikhbabaeva, A. R. Vekua, V. V. Ptushkin |
|
Vol 20, No 1 (2025) |
Early toxicity of high-dose methotrexate in the treatment of non-hodgkin lymphomas in children |
Abstract
PDF (Rus)
|
Z. K. Simavonyan, T. T. Valiev, Yu. E. Ryabukhina, P. A. Zeynalova |
|
Vol 20, No 1 (2025) |
Autologous hematopoietic stem cell transplantation in patients with POEMS-syndrome: a literature review and own data |
Abstract
PDF (Rus)
|
A. V. Popova, M. V. Solovev, A. V. Abakumova, N. K. Arutyunyan, M. V. Soloveva, A. A. Startsev, L. P. Mendeleeva |
|
Vol 19, No 4 (2024) |
Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol |
Abstract
PDF (Rus)
|
M. A. Shervashidze, D. S. Smirnova, T. T. Valiev, N. A. Batmanova |
|
Vol 19, No 4 (2024) |
Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia |
Abstract
PDF (Rus)
|
O. Yu. Vinogradova, M. M. Pankrashkina, L. A. Mukha, A. L. Neverova, M. V. Chernikov, V. V. Ptushkin |
|
Vol 19, No 4 (2024) |
The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol |
Abstract
PDF (Rus)
|
T. T. Valiev, M. A. Shervashidze, I. V. Osipova, T. I. Burlutskaya, G. A. Aleskerova, S. N. Yuldasheva, S. L. Sabantsev, O. V. Paina, N. A. Batmanova, L. S. Zubarovskaya, K. I. Kirgizov, S. R. Varfolomeeva |
|
Vol 19, No 4 (2024) |
Treatment of elderly patients with acute myeloid leukemia: personal experience |
Abstract
PDF (Rus)
|
L. T. Shimanovskaya, E. N. Misyurina, E. A. Baryakh, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, T. N. Tolstykh, D. E. Gagloeva |
|
Vol 19, No 1 (2024) |
Very good partial remission predicts progression-free survival in patients with multiple myeloma |
Abstract
PDF (Rus)
|
A. S. Luchinin, S. V. Semochkin |
|
Vol 19, No 1 (2024) |
How we treat polycythemia vera |
Abstract
PDF (Rus)
|
V. A. Shuvaev, I. S. Martynkevich |
|
Vol 19, No 1 (2024) |
The experience of relapsed Burkitt lymphoma treatment with targeted drugs and autologous/allogeneic stem cell transplantation |
Abstract
PDF (Rus)
|
T. T. Valiev, A. A. Khachatryan, S. V. Goryacheva, N. A. Batmanova, K. I. Kirgizov, S. R. Varfolomeeva |
|
Vol 18, No 4 (2023) |
Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma |
Abstract
PDF (Rus)
|
S. V. Semochkin, V. V. Lunin, М. А. Vernyuk, А. А. Fedenko |
|
Vol 18, No 4 (2023) |
Clinical case of giant extramedullar plasmacytoma in a patient with multiple myeloma |
Abstract
PDF (Rus)
|
G. Sh. Safuanova, Yu. R. Mansurova, A. A. Latypova, А. U. Bagautdinova, T. Yu. Rozhenkova, Ch. Kh. Valiakhmetova |
|
Vol 18, No 4 (2023) |
Combination of lymphoproliferative diseases and pregnancy |
Abstract
PDF (Rus)
|
A. L. Chernyshova, A. A. Chernyakov, N. O. Popova, T. L. Kravchuk, Yu. M. Trushchuk, O. S. Dil’, S. E. Krasil’nikov, V. A. Antipov, A. O. Shumeykina |
|
Vol 18, No 3 (2023) |
Follicular lymphoma in children and adolescents: clinical, diagnostic and therapeutic features |
Abstract
PDF (Rus)
PDF (Eng)
|
T. T. Valiev, A. S. Volkova, M. A. Postoykina, D. S. Abramov, A. R. Karibova, A. A. Odzharova, Yu. E. Ryabukhina, P. A. Zeynalova |
|
Vol 18, No 3 (2023) |
Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults |
Abstract
PDF (Rus)
|
N. E. Konoplya, O. A. Kalenik, I. N. Severin, A. A. Savritskaya, N. M. Bobrova, T. M. Doroshenko, A. S. Portyanko |
|
Vol 18, No 2 (2023) |
Treatment of pediatric relapsed and refractory acute myeloid leukemia |
Abstract
PDF (Rus)
|
F. A. Makhacheva, T. T. Valiev |
|
Vol 18, No 2 (2023) |
Differentiated, immunobased approach of anaplastic large cell lymphoma treatment in children and adolescents: literature review and protocol ALCL-NII DOG-2003 results |
Abstract
PDF (Rus)
|
A. S. Volkova, T. T. Valiev |
|
Vol 18, No 2 (2023) |
Immune checkpoint inhibitors in pediatric hematologic malignancies |
Abstract
PDF (Rus)
|
I. V. Gribkova |
|
Vol 18, No 1 (2023) |
Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience |
Abstract
PDF (Rus)
|
M. A. Granatkin, E. A. Nikitin, M. I. Kislova, E. S. Mikhailov, V. A. Doronin, S. V. Minenko, M. M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. E. Pochtar, S. A. Lugovskaya, Yu. N. Kobzev, V. V. Ptushkin, E. V. Rimashevskaya |
|
Vol 18, No 1 (2023) |
Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial |
Abstract
PDF (Rus)
|
O. A. Aleshina, I. V. Galtseva, E. S. Kotova, G. I. Isinova, T. N. Obukhova, V. N. Dvirnik, A. B. Sudarikov, M. E. Grishunina, O. S. Samoilova, K. D. Kaplanov, V. A. Lapin, S. N. Bondarenko, E. S. Fokina, N. V. Minaeva, T. S. Konstantinova, Yu. V. Sveshnikova, E. E. Zinina, A. S. Antipova, O. Yu. Baranova, E. A. Borisenkova, Yu. O. Davydova, N. M. Kapranov, S. M. Kulikov, Yu. A. Chabaeva, V. V. Troitskaya, E. N. Parovichnikova |
|
No 3 (2008) |
Острый промиелоцитарный лейкоз: новые проблемы и возможные решения |
Abstract
PDF (Rus)
|
|
|
No 3 (2008) |
Efficiency of therapy for acute promyelocytic leukemia in children, by using all-trance retinoic acid, cytosine arabinoside, and smaller-dose anthracyclines |
Abstract
PDF (Rus)
|
E. V. Samochatova, D. D. Baidildina, M. A. Maschan, N. N. Savva, O. P. Khlebnikova, A. V. Shamardina, Yu. E. Mareiko, G. A. Tsaur, T. O. Riger, M. M. Shneider, Yu. V. Rumyantseva, T. V. Nasedkina, T. V. Savitskaya, A. A. Maschan |
|
No 3 (2008) |
Факторы прогноза и результаты терапии первичной системной анапластической крупноклеточной лимфомы |
Abstract
PDF (Rus)
|
A. A. Semenova, N. A. Probatova, E. N. Sorokin, O. L. Timofeeva, I. V. Poddubnaya |
|
No 3 (2008) |
Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol |
Abstract
PDF (Rus)
|
M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky |
|
Vol 17, No 4 (2022) |
A clinical case of the effective combined use of BCL-2 and PI3K inhibitors in the treatment of a patient with an unfavorable chronic lymphocytic leukemia with transformation into diffuse large B-cell lymphoma (Richter’s syndrome) |
Abstract
PDF (Rus)
|
O. A. Rukavitsyn, V. P. Pop, M. V. Drozd, Yu. E. Ryabukhina |
|
1 - 25 of 46 Items |
1 2 > >>
|